Credit Suisse Ag Edwards Lifesciences Corp Put Options Transaction History

Credit Suisse Ag

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $1.58 Million - $1.95 Million	-14,900 Reduced 53.6%	12,900 $1.67 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $1.64 Million - $1.9 Million	20,900 Added 302.9%	27,800 $2.33 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $172,056 - $218,952	2,400 Added 53.33%	6,900 $629,000
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $215,505 - $288,225	4,500 New	4,500 $861,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.